UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Posterior Insular Molecular Changes in Myofascial Pain

Journal of dental research, 2012-05, Vol.91 (5), p.485-490

2012

Volltextzugriff (PDF)

GATA3 Is a Useful Immunohistochemical Marker to Differentiate Variants of Renal Tubular Lesions from Different Segments of Renal Tubules

American journal of clinical pathology, 2021-10, Vol.156 (Supplement_1), p.S152-S153

2021

Volltextzugriff (PDF)

Utilizing lesion diameter and prostate specific antigen density to decide on magnetic resonance imaging guided confirmatory biopsy of prostate imaging reporting and data system score three lesions in African American prostate cancer patients managed with active surveillance

International urology and nephrology, 2022-04, Vol.54 (4), p.799-803

2022

Volltextzugriff (PDF)

Phase I trial of intravesical Bacillus Calmette–Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette–Guérin treatment

World journal of urology, 2021-10, Vol.39 (10), p.3807-3813

2021

Volltextzugriff (PDF)

Morphological Evidence Suggests That Kidney Injury Molecule 1 May Serve as a Proximal Tubule Receptor for SARS-CoV-2: PO0833

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.296-296

2020

Volltextzugriff (PDF)

Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans

The Journal of urology, 2019-03, Vol.201 (3), p.503-509

2019

Volltextzugriff (PDF)

Machine learning-based prediction of upgrading on magnetic resonance imaging targeted biopsy in patients eligible for active surveillance

Urologic oncology, 2022-05, Vol.40 (5), p.191.e15-191.e20

2022

Volltextzugriff (PDF)

Detection of significant prostate cancer through magnetic resonance imaging targeted biopsy of PI-RADS3 lesions in African American patients based on prostate specific antigen density threshold of 0.15 ng/ml 2 : Analysis of patient population from the Vattikuti Urology Institute

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.286-286

2020

Volltextzugriff (PDF)

Systematic Biopsy Does Not Contribute to Disease Upgrading in Patients Undergoing Targeted Biopsy for PI-RADS 5 Lesions Identified on Magnetic Resonance Imaging in the Course of Active Surveillance for Prostate Cancer

Urology (Ridgewood, N.J.), 2019-12, Vol.134, p.168-172

2019

Volltextzugriff (PDF)

The predictive value of magnetic resonance imaging of retinoblastoma for the likelihood of high-risk pathologic features

European journal of ophthalmology, 2019-03, Vol.29 (2), p.262-268

2019

Volltextzugriff (PDF)

Developing a new urine cell flow cytometry analysis of PD-L1 expression and DNA content for diagnosis of bladder cancer

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.60-60

2019

Volltextzugriff (PDF)

MP13-17 PREVALENCE OF CRITERIA FOR GENETIC TESTING ACCORDING TO THE NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN A CONTEMPORARY COHORT OF POST PROSTATECTOMY MEN WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER: THE HENRY FORD HEALTH SYSTEM EXPERIENCE

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP43-09 PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUéRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN HIGH GRADE NONMUSCLE INVASIVE BLADDER CANCER

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP09-20 THE DISTRIBUTION OF COMEDONECROSIS IN INTRADUCTAL VERSUS INVASIVE PROSTATE CANCER: ANALYSIS FROM A LARGE SINGLE CENTER PROSTATECTOMY SERIES

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Urine cell flow cytometry analysis of PD-L1 expression and DNA content for bladder cancer

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.466-466

2019

Volltextzugriff (PDF)

Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria

Histopathology, 2019-06, Vol.74 (7), p.1081-1087

2019

Volltextzugriff (PDF)

Adaptive genetic algorithms combined with high sensitivity single cell-based technology derived urine-based score to differentiate between high-grade and low-grade transitional cell carcinoma of the bladder

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.572-572

2020

Volltextzugriff (PDF)

Assessment of changes in the international prostate symptom score for patients enrolled in a phase I trial of intravesical bacillus Calmette-Guérin combined with intravenous pembrolizumab for recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous bacillus Calmette-Guérin treatment

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16553-e16553

2022

Volltextzugriff (PDF)

The effects of obesity on male fertility

Fertility and sterility, 2018-09, Vol.110 (4), p.e162-e163

2018

Volltextzugriff (PDF)

The effect of ethnicity on semen parameters in men who present with infertility

Fertility and sterility, 2018-09, Vol.110 (4), p.e163-e163

2018

Volltextzugriff (PDF)

Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging

Urology (Ridgewood, N.J.), 2020-12, Vol.146, p.183-188

2020

Volltextzugriff (PDF)

MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP14-14 PROPENSITY SCORE MATCHED STUDY TO EXAMINE THE EFFECT OF RACE ON THE NUMBER OF LESIONS SUSPICIOUS FOR PROSTATE CANCER DETECTED THROUGH MAGNETIC RESONANCE IMAGING OF THE PROSTATE

The Journal of urology, 2018-04, Vol.199 (4), p.e185-e185

2018

Volltextzugriff (PDF)

MP13-03 NEED FOR SYSTEMIC 12-CORE BIOPSY CONCURRENT WITH MRI TARGETED BIOPSY OF PI-RADS 4 AND PI-RADS 5 LESIONS

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

MP30-19 AN UPDATE ON THE PATHOLOGIC FINDINGS OF A LARGE INSTITUTION SERIES OF PATIENTS WITH PROSTATE CANCER AND NO SIGNIFICANT REGIONS OF INTEREST ON PRE-OPERATIVE PELVIC MAGNETIC RESONANCE IMAGING

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(57)
Berichte
(2)

Sprache

Englisch
(59)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Posterior Insular Molecular Changes in Myofascial Pain

GATA3 Is a Useful Immunohistochemical Marker to Differentiate Variants of Renal Tubular Lesions from Different Segments of Renal Tubules

Utilizing lesion diameter and prostate specific antigen density to decide on magnetic resonance imaging guided confirmatory biopsy of prostate imaging reporting and data system score three lesions in African American prostate cancer patients managed with active surveillance

Phase I trial of intravesical Bacillus Calmette–Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette–Guérin treatment

Morphological Evidence Suggests That Kidney Injury Molecule 1 May Serve as a Proximal Tubule Receptor for SARS-CoV-2: PO0833

Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans

Machine learning-based prediction of upgrading on magnetic resonance imaging targeted biopsy in patients eligible for active surveillance

Detection of significant prostate cancer through magnetic resonance imaging targeted biopsy of PI-RADS3 lesions in African American patients based on prostate specific antigen density threshold of 0.15 ng/ml 2 : Analysis of patient population from the Vattikuti Urology Institute

Systematic Biopsy Does Not Contribute to Disease Upgrading in Patients Undergoing Targeted Biopsy for PI-RADS 5 Lesions Identified on Magnetic Resonance Imaging in the Course of Active Surveillance for Prostate Cancer

The predictive value of magnetic resonance imaging of retinoblastoma for the likelihood of high-risk pathologic features

Developing a new urine cell flow cytometry analysis of PD-L1 expression and DNA content for diagnosis of bladder cancer

MP13-17 PREVALENCE OF CRITERIA FOR GENETIC TESTING ACCORDING TO THE NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN A CONTEMPORARY COHORT OF POST PROSTATECTOMY MEN WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER: THE HENRY FORD HEALTH SYSTEM EXPERIENCE

MP43-09 PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUéRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN HIGH GRADE NONMUSCLE INVASIVE BLADDER CANCER

MP09-20 THE DISTRIBUTION OF COMEDONECROSIS IN INTRADUCTAL VERSUS INVASIVE PROSTATE CANCER: ANALYSIS FROM A LARGE SINGLE CENTER PROSTATECTOMY SERIES

Urine cell flow cytometry analysis of PD-L1 expression and DNA content for bladder cancer

Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria

Adaptive genetic algorithms combined with high sensitivity single cell-based technology derived urine-based score to differentiate between high-grade and low-grade transitional cell carcinoma of the bladder

The effects of obesity on male fertility

The effect of ethnicity on semen parameters in men who present with infertility

Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging

MP54-02 TWO-YEAR EFFICACY FOLLOW-UP OF A PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUÉRIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN RECURRENT OR PERSISTENT HIGH-GRADE NON-MUSCLE-INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN TREATMENT

MP14-14 PROPENSITY SCORE MATCHED STUDY TO EXAMINE THE EFFECT OF RACE ON THE NUMBER OF LESIONS SUSPICIOUS FOR PROSTATE CANCER DETECTED THROUGH MAGNETIC RESONANCE IMAGING OF THE PROSTATE

MP13-03 NEED FOR SYSTEMIC 12-CORE BIOPSY CONCURRENT WITH MRI TARGETED BIOPSY OF PI-RADS 4 AND PI-RADS 5 LESIONS

MP30-19 AN UPDATE ON THE PATHOLOGIC FINDINGS OF A LARGE INSTITUTION SERIES OF PATIENTS WITH PROSTATE CANCER AND NO SIGNIFICANT REGIONS OF INTEREST ON PRE-OPERATIVE PELVIC MAGNETIC RESONANCE IMAGING

Suchergebnisse filtern